Pilot Study Seeks to Assess Physical Activity Program in Patients With Gastrointestinal Cancer

Early Phase 1 Trial Investigating Postoperative Treatment Selection After Preoperative Chemotherapy for Gastric Cancers

Phase 1, 2 Trials to Assess Imaging System for Gastrointestinal Cancer Detection

FCT Compared With GD for Muscle-Invasive Bladder Cancer

Frailty Assessment May Benefit Patients Undergoing Radical Cystectomy

Hypofractionated WBI Found Noninferior to Conventionally Fractionated WBI

Younger Breast Cancer Patients at Higher Risk for Osteoporosis

Molecular Mechanisms Underlying Immunosurveillance in Multiple Myeloma Identified

Gly101Val Mutation Directly Causes Resistance to Venetoclax

Can Treatments for Childhood ALL Alter the Gut Microbiome?

Cancer Recurrence: Tackling a Valid Survivor Fear

Researchers are learning that roughly half of survivors live with a moderate to high degree of fear of recurrence, and teaching techniques to better cope with uncertainty is one way to help.

Lower-Dose, Shorter-Duration Chemotherapy Regimens: Is This a Trend?

Lower doses and shorter treatment regimens have the potential to reduce both physical and financial toxicity for patients.

CD19 CAR T-Cell Therapies: "Expect an Evolution"

"CD19 CAR therapy has paved the way for a new field of medicine based on the genetic instruction of T-cell responses," according to Dr Michel Sadelin.